The Future of Medicine
As Nature Medicine celebrates its 30th anniversary, we reflect on the challenges ahead and what the future holds for medicine — and for our journal.
As Nature Medicine celebrates its 30th anniversary, we reflect on the challenges ahead and what the future holds for medicine — and for our journal.
A phase 2 trial of autologous macrophage therapy falls just short of meeting its primary endpoint of improving prognosis, but it is too soon to dismiss this approach; further research and protocol optimization should yield more definitive results.